Boosting innovation for a better understanding of the determinants of health
Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.
Single-stage RIA proposals are capped at 50 pages for Part B. Beyond the core form, several annexes are compulsory: a detailed budget-and-participants table, a declaration of in-kind contribution commitment, and a statement on clinical studies -- even a proposal with no clinical studies at all must upload a declaration saying so. A separate annex for in-kind contributions to additional activities …
Applicants define their own project within this objective, but outcomes must add new understanding of the determinants of health and priority disease areas — covering the whole spectrum from prevention to disease management, and centred on any combination of disease areas, precision diagnostics, personalised medicine or chronic disease management. Digitalisation, AI and regulatory science tools count too, if they serve that goal.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Horizon Europe Grants for Startups: A Founder Guide
A practical guide to Horizon Europe grants for startups, including EIC, consortia, eligibility, Funding & Tenders, TRL, budgets, and EU strategy.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from IHI JU
All grants from this funder →An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies
🇨🇦IHI JU · European Union
Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.
Decode the Immunoscience of age-related diseases
🇪🇺IHI JU · European Union
Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.
IHI European HealthCare Incubator Network
🇨🇦IHI JU · European Union
Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.
AI-Powered Signal Detection in Pharmacovigilance
🇪🇺IHI JU · European Union
Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.
Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions
🇪🇺IHI JU · European Union
Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.
Boosting innovation for people-centred integrated healthcare solutions
🇪🇺IHI JU · European Union
Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.
Similar grants
Browse the directory →
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Horizon Health: Virtual Human Twins for Clinical Decision Support
🇪🇺European Commission · European Union
Funds €10–12M projects that make Virtual Human Twins useful for prevention, diagnosis and safer clinical decisions.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.